Need Help: Providing Innovative and Sustainable Solutions, Call (+91) 6304126453
slide img
Tanvita Life Science

Oncology Intermediates

Tanvita Life Science started by a group of highly committed professionals and incorporated in the year 2024 focussing on anti-cancer products.

Our Services
Our Video!
slide img
Tanvita Life Science

Pyridine Deverties

New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation

Our Services
Our Video!
slide img
Tanvita Life Science

Research & Development

We have a strong workforce including highly skilled personnel and professionals. We are also very well focussed towards the technological expertise and product development.

Our Services
Our Video!
background

Pazopanib Intermediates

Ibrutinib Intermediates

Imatinib Intermediates

Lenalidomide Intermediates

Privileged Access Management

Software License Management

Timely Service Delivery & Incident Resolutions!!

About Us

Tanvita Life Science started by a group of highly committed professionals and incorporated in the year 2024 focussing on anti-cancer products. We would like to introduce ourselves as one of the cGMP facility module bulk drug intermediate manufacturing unit near Hyderabad, India. We give top priority to good quality product supply, proper documentation, customer satisfaction and a clean environment. We assure the above with our experience, expertise and commitment. We follow all the standards, quality methodologies and other scientifically derived technologies to rush in the competitive pharma world. We follow all the standards, quality methodologies and other scientifically derived technologies to rush in the competitive pharma world.

Our company is specialised in Research Development of the most complex products under regulatory. We develop a product under lab scale with different techniques and transfer the technology to the esteemed organisations all around the world. Also, we do work under commercial aspects through contract basis in a GMP regulatory plant. This company builds cost effective processes with short time cycled route of synthesis (ROS). Our Organisation is purely eco friendly.

  • Oncology Intermediates
  • Pyridine Deverties
  • Pazopanib Intermediates
  • Ibrutinib Intermediates
  • Imatinib Intermediates
  • Lenalidomide Intermediates
about
thumb

We follow all the standards, quality methodologies and other scientifically derived technologies to rush in the competitive pharma world.

Satisfied Users Over The Globe

Success Stories

map
author thumb
As one of the world's largest anti-cancer products Providers with group of highly committed professionals and professional support staff are ready to help.
author thumb
As one of the world's largest anti-cancer products Providers with group of highly committed professionals and professional support staff are ready to help..
author thumb
As one of the world's largest anti-cancer products Providers with group of highly committed professionals and professional support staff are ready to help..
author thumb
As one of the world's largest anti-cancer products Providers with group of highly committed professionals and professional support staff are ready to help..
author thumb
As one of the world's largest anti-cancer products Providers with group of highly committed professionals and professional support staff are ready to help..
background

Oncology Intermediates

We have a strong workforce including highly skilled personnel and professionals. .

or

Pyridine Deverties

We have a strong workforce including highly skilled personnel and professionals. .

Products

Oncology Intermediates

S.No
1
Name of the Product
5-Deoxy-1,2,3-Tri-O-acetyl D-ribofuranoside
Cas.No
62211-93-2
Structure
background
End User
Capecitabine Intermediates
2
2,3-Di-O-Acetyl-5-Deoxy-5-Fluoro Cytidine
161599-46-8
background
Capecitabine Intermediates
3
5-deoxi-5-fluoro-N-(pentyloxy)carbonyl cytidine
162204-20-8
background
Capecitabine Intermediates
4
5-Amino-2-methyl benzene sulfonamide
6973-09-7
background
Pazopanib Intermediates
5
2,3-Dimethyl-2H-Indazole6-amine Hydrochloride
635702-60-2
background
Pazopanib Intermediates
6
3-Amino-5-(4-phenoxyphenyl)-(1H)-pyrazole-4-carbonitrile
330792-70-6
background
Ibrutinib Intermediates
7
3-(4-Phenoxyphenyl)-1Hpyrazolo[3,4-d]pyrimidin4-amine
330786-24-8
background
Ibrutinib Intermediates
8
4-chloro-7-Methoxyquinoline-6-carboxaMide
417721-36-9
background
Lenvatinib Intermediates
9
2-Amino-N-(2-chloro6-methylphenyl)thiazole-5-carboxamide
302964-24-5
background
Dasatinib Intermediates
10
4,6-Dichloro-2-methylpyrimidine
1780-26-3
background
Dasatinib Intermediates
11
N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine
231278-20-9
background
Lapatinib Intermediates
12
N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
162012-67-1
background
Afatinib Intermediates
13
5-Formyl-2,4-dimethyl-1Hpyrrole-3-carboxylic acid
253870-02-9
background
Sunitinib Intermediates
14
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1Hpyrrole-3-carboxamide
356068-86-5
background
Sunitinib Intermediates
15
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
641569-94-0
background
Nilotinib Intermediates
16
Diethyl L-glutamate hydrochloride
1118-89-4
background
Pemetrexed Intermediates
17
N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide
1139453-98-7
background
Nintedanib Intermediates
18
N-(4-aminophenyl)-Nmethyl-2-(4-methylpiperazin-1-yl)acetamide
262368-30-9
background
Nintedanib Intermediates
19
Methyl 2-bromomethyl-3-nitrobenzoate
98475-07-1
background
Lenalidomide Intermediates
20
2,6-Dioxopiperidine-3-ammonium chloride
24666-56-6
background
Lenalidomide Intermediates
21
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
827026-45-9
background
Lenalidomide Intermediates
22
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
152460-10-1
background
Imatinib Intermediates
23
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride
106261-49-8
background
Imatinib Intermediates
24
5-Formyl-2,4-dimethyl-1Hpyrrole-3-carboxylic acid
253870-02-9
background
Sunitinib Intermediates
25
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1Hpyrrole-3-carboxamide
356068-86-5
background
Sunitinib Intermediates
26
tert-butyl 4-((E)-3-(dimethylamino)acryloyl)piperidine-1-carboxylate 98%
960201-86-9 or 1799799-87-3
background
Zanubrutinib Intermediates
27
3-Bromo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
83255-86-1
background
Sapatisertinib Intermediates
28
1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid
849217-48-7
background
Cabozantinib Intermediates
29
4-chloro-6,7-dimethoxyquinoline
35654-56-9
background
Capecitabine Intermediates

Products

Pyridine Deverties

S.No
1
Name of the Product
2-Bromopyridne
Cas.No
109-04-6
Structure
background
End User
Carbinoxamine; Chlorpyramine; Disopyramide; Pipradrol; Triprolidine; Lafutidine; Piclozotan; Taprizosin; Atazanavir
2
3-Bromopyridne
626-55-1
background
Intermediate for Ofloxacin Abiraterone
3
Pyridine-2-carbaldehyde
1121-60-4
background
Bisacodyl; Sodium picosulfate; Pralidoxime iodide, Carbinoxamine
4
Pyridine-3-carbaldehyde
500-22-1
background
Abarelix; Cetrorelix; Ganirelix; Indinavir; Elarofiban
5
Pyridine-4-carbaldehyde
872-85-5
background
Obidoxime; Trimedoxime; Donepezil
6
4-Aminopyridine
504-24-5
background
Indoramin; Lexipafant; Milverine; Octenidine; Pinacidil; Timiperone
7
Methyl Nicotinate
93-60-7
background
Paroxetine, Afegostat, Aprikalim, Nornicotine, Methyl Nicotonoylacetate
8
Methyl Isonicotinate acid
2459-09-8
background
Obidoxime; Trimedoxime; Donepezil
9
Propargyl Bromide
106-96-7
background
Rasagiline